Liraglutide results in significant weight loss in patients with bipolar disorder
Published:4 June 2024
DOI: 10.1002/pu.31179
Abstract
A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.